• Apnimed granted 14 new non-executive employees non-qualified stock options covering 331,000 shares on Nov. 2, 2026, under its 2026 Inducement Plan.
• The options carry an exercise price of $15.4 per share, equal to the closing trading price on the grant date.
• Vesting begins with 25% on each employee’s first start-date anniversary, followed by equal monthly installments over three years, subject to continued employment.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Apnimed Inc. published the original content used to generate this news brief via GlobeNewswire (Ref. ID: 202611051605PRIMZONEFULLFEED9870828) on November 05, 2026, and is solely responsible for the information contained therein.